Key Market Indicators
Belgian antihypertensive medicine sales are predicted to reach almost $47 million by 2026. In 2021, they totaled $41.25 million, a 2.4% year-on-year growth rate. Since 2007, the market has grown by 7.5% every year. This year, Belgium ranked seventh, with Greece overtaking it to take the number one spot. Italy, Spain, and Australia came in second, third, and fourth place respectively.
